Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease ; volume:10 ; number:1 ; day:5 ; month:11 ; year:2020 ; pages:1-12 ; date:12.2020
Scientific reports ; 10, Heft 1 (5.11.2020), 1-12, 12.2020
- Creator
-
Stepanova, P.
Srinivasan, V.
Lindholm, D.
Voutilainen, M. H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-75439-1
- URN
-
urn:nbn:de:101:1-2020121320162936250374
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stepanova, P.
- Srinivasan, V.
- Lindholm, D.
- Voutilainen, M. H.
- SpringerLink (Online service)
Other Objects (12)
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
Huntington
Quinic acid protects against the development of Huntington’s disease in Caenorhabditis elegans model
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
Treatment of Irritability in Huntington’s Disease
G3 Hedonic olfaction in huntington’s disease
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
Huntington
Quinic acid protects against the development of Huntington’s disease in Caenorhabditis elegans model
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
Treatment of Irritability in Huntington’s Disease
G3 Hedonic olfaction in huntington’s disease
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
Huntington
Quinic acid protects against the development of Huntington’s disease in Caenorhabditis elegans model
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
Treatment of Irritability in Huntington’s Disease
G3 Hedonic olfaction in huntington’s disease